Effects of dipeptidyl peptidase‐4 inhibition in vivo: Dipeptidyl peptidase‐4 inhibitor/gut microbiome crosstalk suggests novel therapeutic options for diabetes management
oleh: Takuma Yasuda, Norio Harada, Nobuya Inagaki
| Format: | Article |
|---|---|
| Diterbitkan: | Wiley 2024-06-01 |
Deskripsi
No description available for this item.